When it comes to infectious disease clinical research, it is a race. Now, in the midst of a global pandemic, there is immense time pressure to find a solution for COVID-19. In response, sponsors, with support from regulators, health authorities and governments are starting clinical trials at a record pace.
Accelerating infectious disease trials requires a new level of coordination and communication among research staff, sponsors and monitors to balance speed, safety, data quality and integrity. The use of paper-based study documents and onsite monitoring are not practical in fast-moving infectious disease trials – and right now with COVID-19 neither are even possible. Personal Protective Equipment (PPE) is hardly conducive to consulting a protocol in a binder or a desktop portal. The challenge is to adapt while moving quickly and minimizing errors.
Time is precious and speed is critical.
Teckro clinical trial software connects research sites, monitors and study teams so that only the most current study information is guiding decisions during infectious disease trials. Through their smartphone or any digital device, current study documents are always on hand for doctors and nurses, study coordinators and monitors.
Directed communication alerts monitors and site staff to specific study changes relevant to them. Unlike other conventional impromptu communication channels, Teckro is compliant with industry regulations, including 21 CFR Part 11. Communication is centralized within Teckro, which helps with continuity regardless of staff turnover. And your regulatory and clinical trial team members can export individual messages, or in bulk, for inclusion into your TMF.
When site staff have immediate access to critical study information, they enroll the right patients faster and have fewer deviations. Here’s how Teckro helps with clinical trial operations for infectious diseases:
Teckro is cloud-based software, which means trials in infectious diseases can be fully operational very quickly. Sponsor’s study teams provide details of the site personnel and monitors they wish to have access to the study. Users have the choice to access Teckro with a dedicated mobile app, downloadable from their usual app store. Alternatively, they can access Teckro from any device through a secure website. New users register their accounts with Teckro in a couple of simple steps, while users already using Teckro can simply switch between studies.
Given the extraordinary challenges with COVID-19, we have added some new capabilities to allow study teams to quickly provide specific guidance. Our team of experts will work with you to determine how to best set up Teckro to support your infectious disease trials.